
دعبید
لابراتوارداروسازی دکترعبیدی
سود 3 Months :
| تریدر | نوع پیام | منبع | زمان انتشار | مشاهده پیام |
|---|---|---|---|---|
![]() شرکت کوبل دارو | خرید | 11/4/2025 | ||
![]() شرکت گروه مدیریت سرمایه لیان | خرید | 11/4/2025 | ||
![]() شرکت آرین الوندپارس | خرید | 11/4/2025 | ||
![]() شرکت مدیریت توسعه سپندفردا | خرید | 11/4/2025 |
پیامهای دعبید

شرکت گروه مدیریت سرمایه لیان
Lian Capital Management Group Company purchased 2842.304 million shares of Dabeid on 08/13/1404 and currently has 18.948% of Dabeid's shares in its stock portfolio.

شرکت کوبل دارو
Kobel Daru Company bought 9782.942 million shares of Dabeid on 08/13/1404 and currently has 65.219% of Dabeid's shares in its stock portfolio.

شرکت مدیریت توسعه سپندفردا
Sepandfarda Development Management Company purchased 191.739 million Daabid shares on 08/13/1404 and currently has 1.278% of Daabid shares in its stock portfolio.

شرکت آرین الوندپارس
Arin Elvandpars Company bought 593.105 million shares of Doabid on 08/13/1404 and currently has 3.447% of Daabid's shares in its stock portfolio.

شرکت آرین الوندپارس
Arin Elvandpars Company sold 13.800 million Daabid shares on 08/12/1404 and currently has 3.262% of Daabid shares in its stock portfolio.

شرکت آرین الوندپارس
Arin Elvandpars Company sold 8.500 million Daabid shares on 08/11/1404 and currently has 3.296% of Daabid shares in its stock portfolio.

شرکت آرین الوندپارس
Arin Alvandpars Company sold 124.000 million shares of Doabid on 08/10/1404 and currently has 3.317% of Daabid's shares in its stock portfolio.

شرکت کوبل دارو
Cochler Drug Company has sold 0.087 million shares on 14/07/13 and currently holds 65.219 % of Dabid's shares in its portfolio.

شرکت کوبل دارو
Cochler Drug Company bought 2.400 million shares on 14/05/18 and currently holds 65.219 % of Dabid's shares in its joint portfolio.

شرکت کوبل دارو
Cochler Daru Company bought 0.300 million shares on 05/05/05 and currently accounts for 65.213 % of Dabid's shares in its joint portfolio.
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.